Scholarly Index
Michael D. Smith
KalVista Pharmaceuticals (United States); 1,985 total citations; 53 total publications; best world rank #502
KalVista Pharmaceuticals (United States)
1,985Total citations
53Total publications
24H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Burkholderia infections and melioidosis | Lifetime | 502 | US 102 | 79.76 |